Michael R. Abern
Experienced in Urinary Incontinence

Dr. Michael R. Abern

Urology
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
On Staff At
Clinical Trials:Currently Recruiting for 3 Trials
Accepting New Patients
Offers Telehealth

Experienced in Urinary Incontinence
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I am a urologic oncologist who specializes in the diagnosis and surgical treatment of tumors of the urinary tract in men and women. I employ minimally invasive techniques as much as possible in order to maximize quality of life and recovery from treatment. Examples include robotic surgical removal of the prostate, kidney tumors, and bladder with complete robotic reconstruction. I am passionate about researching tests and treatments that will help my patients achieve cure of their cancers. I believe this starts with understanding risk factors for cancer to guide screening and early detection of tumors. I enjoy listening to my patients and understanding their goals of care. I believe that cancer care is a team sport and the patient is the captain. I collaborate with other specialists to make a comprehensive treatment plan including but not limited to surgery. In my free time, I enjoy exploring the outdoors with my wife and two daughters.

Dr. Abern is rated as an Experienced provider by MediFind in the treatment of Urinary Incontinence. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in NC
Board Certifications
American Board Of Urology, Urology
Fellowships
Urologic Oncology, Duke University
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Duke Cancer Center
20 Duke Medicine Cir, Durham, NC 27710
Call: 919-681-6900

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Other
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial
The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial
Enrollment Status: Completed
Publish Date: October 05, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

107 Total Publications

Comparing the Perioperative and Oncological Outcomes of Open Versus Minimally Invasive Inguinal Lymphadenectomy in Penile Cancer: A Systematic Review and Meta-Analysis.
Comparing the Perioperative and Oncological Outcomes of Open Versus Minimally Invasive Inguinal Lymphadenectomy in Penile Cancer: A Systematic Review and Meta-Analysis.
Journal: Cancers
Published: July 20, 2025
View All 107 Publications
Similar Doctors
Andrew C. Peterson
Distinguished in Urinary Incontinence
Dr. Andrew C. Peterson
Urology
Distinguished in Urinary Incontinence
Dr. Andrew C. Peterson
Urology

Duke Urology Clinic - Clinic 1G

40 Duke Medicine Cir, 
Durham, NC 
 (0.1 miles away)
919-684-2446
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I’m a reconstructive urologic surgeon who also cares for cancer survivors. Cancer survivorship care focuses on providing patients and families relief from the symptoms, pain and distress that may develop after and during cancer therapy. I find it gratifying to help a patient that has a significant problem and increase their quality of life. I decided I wanted to go into medicine while in high school after feeling a sense of duty to serve those around me; this was the same calling that drew me to service in the military for 23 years. I came to Duke after my active duty service in the Army was completed in 2010 and since then, my family has really become a “Duke family.” We regularly attend Duke Football games and other sporting and social events. My wife also works here, my kids have expressed interest in attending college here and we all regularly wear the Duke blue colors on weekends. Dr. Peterson is rated as a Distinguished provider by MediFind in the treatment of Urinary Incontinence. His top areas of expertise are Stress Urinary Incontinence, Urinary Incontinence, Obstructive Uropathy, Hernia Surgery, and Reconstructive Urology Surgery.

Distinguished in Urinary Incontinence
Dr. Catherine A. Matthews
Urology | Obstetrics and Gynecology
Distinguished in Urinary Incontinence
Dr. Catherine A. Matthews
Urology | Obstetrics and Gynecology

Wake Forest University Health Sciences

3903 N Elm St, 
Greensboro, NC 
 (49.2 miles away)
336-713-4944
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Catherine Matthews is an Urologist and an Obstetrics and Gynecologist in Greensboro, North Carolina. Dr. Matthews is rated as a Distinguished provider by MediFind in the treatment of Urinary Incontinence. Her top areas of expertise are Uterine Prolapse, Bowel Incontinence, Interstitial Cystitis, Hysterectomy, and Oophorectomy. Dr. Matthews is currently accepting new patients.

Aaron C. Lentz
Distinguished in Urinary Incontinence
Dr. Aaron C. Lentz
Urology
Distinguished in Urinary Incontinence
Dr. Aaron C. Lentz
Urology

Duke Raleigh Hospital

3400 Wake Forest Rd, 
Raleigh, NC 
 (21.5 miles away)
919-954-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I find the reconstructive aspect of urologic surgery the most exciting and challenging from a strategic and surgical perspective. Reconstructive urology provides an opportunity to help improve and to restore function as well as aesthetics for the patient who has endured injury, cancer, previous surgical complications, or congenital conditions. The uniqueness of each case poses a tactical and a surgical challenge, requiring a highly individualized and carefully planned and executed surgical approach to address the problem and underlying anatomical and medical cause. Within the emerging subspecialty of reconstructive urology, I focus on complex urethral stricture disease utilizing anastomotic and substitution urethroplasty; management of upper urinary tract obstruction; urinary fistula repair; prosthetic urology including penile implants for erectile dysfunction, as well as artificial urinary sphincters and minimally invasive slings for male stress urinary incontinence; penile reconstruction for Peyronie’s disease; and a comprehensive approach to male sexual health and male wellness. Dr. Lentz is rated as a Distinguished provider by MediFind in the treatment of Urinary Incontinence. His top areas of expertise are Stress Urinary Incontinence, Urinary Incontinence, Erectile Dysfunction (ED), Prostatectomy, and Ureteroscopy.

VIEW MORE URINARY INCONTINENCE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abern's expertise for a condition
ConditionClose
  • Elite
  • Prostate Cancer
    Dr. Abern is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Distinguished
  • Bladder Cancer
    Dr. Abern is
    Distinguished
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Abern is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Advanced
  • Chromophobe Renal Cell Carcinoma
    Dr. Abern is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Abern is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Prostate Cancer
    Dr. Abern is
    Advanced
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Abern is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Muscle Invasive Bladder Cancer
    Dr. Abern is
    Advanced
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Nephrectomy
    Dr. Abern is
    Advanced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
View All 15 Advanced Conditions
  • Experienced
  • Bacterial Prostatitis
    Dr. Abern is
    Experienced
    . Learn about Bacterial Prostatitis.
    See more Bacterial Prostatitis experts
  • Bilateral Hydronephrosis
    Dr. Abern is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Outlet Obstruction
    Dr. Abern is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Reconstruction
    Dr. Abern is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Bladder Stones
    Dr. Abern is
    Experienced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Choriocarcinoma
    Dr. Abern is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.